Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Avita Medical Inc.

Avita Medical Inc. (RCEL) Stock Overview

Explore Avita Medical Inc.’s financial performance, market position, analyst ratings, and future outlook.

RCEL●NASDAQ
HealthcareMedical - Devices
$8.01
$0.11(1.35%)
U.S. Market opens in 3h 2m

Avita Medical Inc. (RCEL)

Meyka AI Score

Z

Key Financials

Market Cap199M
P/E Ratio-5.64
EPS (TTM)$-1.57
ROE2.32%
Fundamental Analysis

AI Price Forecasts

1 Month$6.06
3 Months$7.17
1 Year Target$2.34

RCEL Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Avita Medical Inc. (NASDAQ: RCEL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Avita Medical Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RCEL on the NASDAQ shows an RSI of 77.92, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $2.34 for the NASDAQ listing.

Key metrics behind Avita Medical Inc.'s NASDAQ-traded stock include a P/E ratio of -5.64 and a market capitalization of 199M. Combined with our AI analysis, these give both institutional and retail investors a clear view of RCEL on the NASDAQ.

Price Performance (NASDAQ: RCEL)

1-Day Change
-1.35%
5-Day Change
33.28%
1-Month Change
102.78%
3-Month Change
88.03%
6-Month Change
92.55%
Year-to-Date (YTD) Change
132.17%
1-Year Change
39.06%
3-Year Change
-56.21%
5-Year Change
-53.94%
All-Time (Max) Change
-67.96%

Contact Information

https://avitamedical.com
661 367 9170
28159 Avenue Stanford, Valencia, CA, 91355

Company Facts

2,260 Employees
IPO DateMay 14, 2012
CountryUS
Actively Trading

Frequently Asked Questions